Copyright
©The Author(s) 2020.
World J Gastroenterol. Jul 14, 2020; 26(26): 3737-3749
Published online Jul 14, 2020. doi: 10.3748/wjg.v26.i26.3737
Published online Jul 14, 2020. doi: 10.3748/wjg.v26.i26.3737
Figure 5 Immunofluorescence analysis of protein arginine methyltransferase and programmed death-ligand-1 in tumor tissue.
Protein arginine methyltransferase 1 is shown in red, programmed death-ligand-1 is shown in green, and DAPI staining indicates the nucleus. Scale bars = 100 µm. PRMT: Protein arginine methyltransferase; PD-L1: Programmed death-ligand-1; DAPI: 2-(4-Amidinophenyl)-6-indolecarbamidine dihydrochloride.
- Citation: Zheng NN, Zhou M, Sun F, Huai MX, Zhang Y, Qu CY, Shen F, Xu LM. Combining protein arginine methyltransferase inhibitor and anti-programmed death-ligand-1 inhibits pancreatic cancer progression. World J Gastroenterol 2020; 26(26): 3737-3749
- URL: https://www.wjgnet.com/1007-9327/full/v26/i26/3737.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i26.3737